Get the Stockscreener App
1.785
4.65%
0.065
Health Catalyst Inc stock is traded at $1.785, with a volume of 108.41K.
It is up +4.65% in the last 24 hours and down -17.05% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$1.72
Open:
$1.72
24h Volume:
108.41K
Relative Volume:
0.14
Market Cap:
$126.25M
Revenue:
$299.48M
Net Income/Loss:
$-86.45M
P/E Ratio:
-1.19
EPS:
-1.5
Net Cash Flow:
$-17.32M
1W Performance:
+0.56%
1M Performance:
-17.05%
6M Performance:
-45.45%
1Y Performance:
-60.18%
1-Day Range:
$1.70
$1.805
1-Week Range:
$1.56
$1.845
52-Week Range:
$1.56
$5.062
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
1.785 | 121.66M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
186.25 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
52.10 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.73 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
81.54 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.59 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-08-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
Benjamin Albert notifies sale of 4,966 restricted HCAT shares (NASDAQ: HCAT) - Stock Titan
Bentley Systems, Guidewire Software, Health Catalyst, and Doximity Shares Skyrocket, What You Need To Know - Finviz
Health Catalyst to Announce Fourth Quarter and Year End 2025 Operating Results and Host Conference Call on Thursday, March 12, 2026 - Bitget
How to listen to Health Catalyst’s March 12 results call - Stock Titan
Value Recap: Does Health Catalyst Inc outperform in volatile marketsMarket Activity Report & Capital Protection Trade Alerts - baoquankhu1.vn
Revenue per share of Health Catalyst, Inc. – DUS:2YP - TradingView
Primecap Management Co. CA Sells 617,620 Shares of Health Catalyst, Inc. $HCAT - MarketBeat
Health Catalyst (HCAT) CEO logs large RSU grants and tax-driven share sale - Stock Titan
Health Catalyst (NASDAQ: HCAT) CPO gets RSU, PRSU grants and tax sell-to-cover - Stock Titan
Large stock grants and tax-driven share sale at Health Catalyst (HCAT) - Stock Titan
FOMO Trade: Should I set a stop loss on Health Catalyst Inc2025 Biggest Moves & Safe Entry Zone Identification - baoquankhu1.vn
Benjamin Landry to sell 6,317 HCAT restricted shares (HCAT) - Stock Titan
Health Catalyst (HCAT) insider sale notice: 4,471 shares via Morgan Stanley - Stock Titan
Health Catalyst (NASDAQ: HCAT) exec to sell 28,875 restricted shares via MS - Stock Titan
Health Catalyst, Inc (HCAT) Stock Analysis: Potential Upside of 116% Piques Investor Interest - DirectorsTalk Interviews
How The Health Catalyst (HCAT) Story Is Shifting After Target Cut And CEO Transition - Yahoo Finance
Whetstone Capital Advisors, LLC Increases Stake in Health Cataly - GuruFocus
Health Catalyst Names New CEO Amid Board Restructuring - TipRanks
What are Health Catalyst Inc.’s recent SEC filings showingPortfolio Return Summary & Low Drawdown Investment Ideas - mfd.ru
Health Catalyst Inc expected to post earnings of 9 cents a shareEarnings Preview - TradingView
Health Catalyst, Inc (HCAT) Stock Analysis: Exploring the 118.93% Potential Upside for Opportunistic Investors - DirectorsTalk Interviews
Health Catalyst appoints Ben Albert as CEO - TipRanks
Health Catalyst appoints Ben Albert as CEO, plans to reduce board size - Investing.com Nigeria
Health Catalyst (HCAT) Restructures Board Leadership - GuruFocus
Health Catalyst names new CEO; downsizes board (HCAT:NASDAQ) - Seeking Alpha
Health Catalyst, Inc. Announces Appointment of Ben Albert as Chief Executive Officer, Effective February 12, 2026 - marketscreener.com
Health Catalyst Appoints Ben Albert as Chief Executive Officer - Finviz
Health Catalyst names Ben Albert CEO as Daniel Burton accelerates retirement - TradingView
Health Catalyst (HCAT) to Release Earnings on Wednesday - MarketBeat
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Health Catalyst (NASDAQ:HCAT) Trading Down 6%Time to Sell? - MarketBeat
Zoom, Akamai Technologies, Health Catalyst, SentinelOne, and PubMatic Stocks Trade Down, What You Need To Know - The Globe and Mail
Aug Closing: Does Health Catalyst Inc. have a sustainable dividendJuly 2025 Sector Moves & Stepwise Trade Signal Implementation - mfd.ru
Down 20.4% in 4 Weeks, Here's Why Health Catalyst (HCAT) Looks Ripe for a Turnaround - Finviz
Rally Mode: Does Health Catalyst Inc outperform in volatile marketsBull Run & Safe Entry Momentum Tips - baoquankhu1.vn
Why analysts recommend Health Catalyst Inc. (2YP) stockJuly 2025 Momentum & Capital Protection Trade Alerts - mfd.ru
Down 21.4% in 4 Weeks, Here's Why Health Catalyst (HCAT) Looks Ripe for a Turnaround - Finviz
Risk On: How Health Catalyst Inc. stock reacts to job market dataTrade Analysis Report & Weekly Breakout Stock Alerts - mfd.ru
Improved Revenues Required Before Health Catalyst, Inc. (NASDAQ:HCAT) Shares Find Their Feet - simplywall.st
Why Health Catalyst Inc. stock is considered a top pickPortfolio Performance Summary & Daily Chart Pattern Signal Reports - mfd.ru
Health Catalyst and F5 Stocks Trade Down, What You Need To Know - Finviz
Health Catalyst, Inc (HCAT) Stock Analysis: Exploring A Potential Upside Of Nearly 95% - DirectorsTalk Interviews
3 Cash-Burning Stocks Walking a Fine Line - Finviz
Will Health Catalyst Inc. stock maintain growth storyJuly 2025 Intraday Action & Stepwise Swing Trade Plans - mfd.ru
Health Catalyst leverages AI to enhance clinical outcomes - Traders Union
What drives Health Catalyst Incs stock priceTrade Performance Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn
Best Places to Work 2025 - Modern Healthcare
3 of Wall Street's Favorite Stocks We Approach with Caution - Finviz
Marquis Who's Who Honors Kristin Acree for Expertise in Public Health - lelezard.com
Why Health Catalyst (HCAT) Stock Is Trading Lower Today - Finviz
How Health Catalyst Turns Analytics Into Action Clinicians Actually Use - Healthcare IT Today
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.87%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):